TMAO to the rescue of pathogenic protein variants

• Published in: Biochimica et biophysica acta. General subjects Vol. 1866; no. 11; p. 130214
• Main Authors: Kumari, Kritika, Singh, Khuraijam Surjalal, Singh, Kuldeep, Bakhshi, Radhika, Singh, Laishram Rajendrakumar
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 01.11.2022
• Subjects: Chemical chaperone; Functional rescue; human diseases; hydrostatic pressure; Mutant protein; mutants; Protein conformational diseases; protein folding; protein subunits; Proteopathies; therapeutics; toxicity; trimethylamine; urea; Chemical chaperone; Proteopathies; Mutant protein; Protein conformational diseases; Functional rescue
• ISSN: 0304-4165; 1872-8006; 1872-8006
• DOI: 10.1016/j.bbagen.2022.130214

Trimethylamine N-oxide (TMAO) is a chemical chaperone found in various organisms including humans. Various studies unveiled that it is an excellent protein-stabilizing agent, and induces folding of unstructured proteins. It is also well established that it can counteract the deleterious effects of urea, salt, and hydrostatic pressure on macromolecular integrity. There is also existence of large body of data regarding its ability to restore functional deficiency of various mutant proteins or pathogenic variants by correcting misfolding defects and inhibiting the formation of high-order toxic protein oligomers. Since an important class of human disease called “protein conformational disorders” is due to protein misfolding and/or formation of high-order oligomers, TMAO stands as a promising molecule for the therapeutic intervention of such diseases. The present review has been designed to gather a comprehensive knowledge of the TMAO's effect on the functional restoration of various mutants, identify its shortcomings and explore its potentiality as a lead molecule. Future prospects have also been suitably incorporated. •TMAO could restore function to the function to temperature sensitive mutant proteins.•TMAO inhibits formation of toxic high-order oligomers.•TMAO could prevent ERAD-mediated degradation of mutant proteins and help to correct trafficking defect.•TMAO is a potential molecule that can be used for therapeutic interventions of protein conformational disorders.